HOME >> BIOLOGY >> NEWS
Procter & Gamble donates proprietary "super aspirin" technology to Vanderbilt University

NASHVILLE, TN (November 2, 2000) - The next "super aspirin" may be among a collection of 196 patents and pending patents given today to Vanderbilt University by Cincinnati-based Procter & Gamble (NYSE: PG). P&G's proprietary COX-2 Inhibitor Technology shows promise in improving the safety of medications commonly taken for pain, inflammation, and fever reduction.

Along with the patents, P&G is donating all associated intellectual property. As the sole new owners of the technology, Vanderbilt will benefit from all future revenues after the technology is further developed, tested, and commercialized.

"We are pleased that Vanderbilt's international reputation in the area of eicosanoids (COX products) has been affirmed by this generous gift of intellectual property, and we are excited with the opportunity to develop it into something of clinical value," said Lee E. Limbird, Ph.D., associate vice chancellor for Research.

Procter & Gamble's external consultants identified Vanderbilt as the university that is most uniquely qualified to further develop the COX-2 Inhibitor Technology due to their on-going leadership in COX-2 research. In addition, Vanderbilt's Office of Enterprise Development gives the framework for commercializing the technology.

"We're excited that Vanderbilt will continue to develop and test this significant technology, and that Vanderbilt will benefit both financially and academically from this donation," said P&G's Chief Technology Officer Gil Cloyd. "Best of all, we'll get to see this promising science furthered to improve peoples' lives - even if it will no longer be in P&G hands."

The gift of COX-2 Inhibitor Technology is the sixth in a series of Procter & Gamble technology donations to leading universities and research institutions.

About COX-2 inhibitor technology

COX-2 Inhibitor Technology compounds block the action of an enzyme called cyclooxygenase-2 (COX-2), and like other recently marketed COX-2 inhi
'"/>

Contact: Leigh MacMillan
leigh.macmillan@mcmail.vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
1-Nov-2000


Page: 1 2 3

Related biology news :

1. Derek R. Lovley receives 2004 Proctor & Gamble Award from American Society for Microbiology
2. UC Santa Barbara donates discovery to OneWorld Health that may speed disease treatment
3. Kimberly-Clark Worldwide donates intellectual property to Rensselaer
4. Dupont donates patents to UCSD
5. Donation valued at $12 million: Hoechst Research & Technology donates cut resistant fiber patents to Clemson University
6. Zengen, Inc. receives patent application approval for proprietary peptide technology
7. CWRU physicists invent "supershielding" for MRI devices
8. Yale digital diagnostic technology is basis of new company, HistoRx Inc.
9. AACR applauds NCI initiative on nanotechnology
10. Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies
11. New imaging technology at Joslin shown to detect early signs of type 1 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2020)... ... July 21, 2020 , ... ... innovation in technology and compliance, announces a new solution to manage regulated workloads ... every layer of their technology stack complies with FDA and global regulations. USDM's ...
(Date:7/10/2020)... ... 2020 , ... Today CJ BIO announced the first in a series of ... taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles across a ... July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT ...
(Date:7/1/2020)... , ... July 01, 2020 , ... ... it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located ... existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot facility will ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as ... cover the history of eSource, the reasons it did not take off as quickly ... site source, the industry is moving towards capturing data electronically for clinical trials and ...
(Date:7/22/2020)... TORONTO (PRWEB) , ... July 22, 2020 , ... Join ... and John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... is the regulating body in China for drugs and medical devices. Specifically, for medical ...
(Date:7/18/2020)... Ohio (PRWEB) , ... July 16, 2020 , ... ... data solutions to aid in the early detection and prevention of high-burden diseases, ... to enable US-based hospitals and healthcare organizations to utilize existing data in order ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... today that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive ... PathSensors to move into the point-of-care diagnostic market, focusing initially on the ...
Breaking Biology Technology:
Cached News: